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Some R-0-(CH2)2-N-^i-J?2 type of amino alkylethylether derivatives where the R-radical 
were phenyl or substituted phenyl or naphthoyl-radical, while the N - R r R i meant diethylamino-
pirrolidino-, morpholino-, piperidino-radical were prepared with routine techniques. A few quater-
nary derivatives have been also prepared from this compounds. Examining the pharmacological 
activities the tertiary compounds showed antiadrenalitic activity, among the quaternary derivatives 
however, highly active ganglioplegic compound could be noted. 
Previously the correlation of pharmacological effect and chemical structure 
was treated concerning the different substituted carbonic ester [1—3], tertiary 
aminoaryl-propene and propane [4], aryl-aminothioether and sufoxide [5], acidamides 
[6] etc. Some drugs had been selected from these groups and their pharmacological 
introduction is under way (Gedeon Richter Pharmacological Works, Budapest). 
The antiadrenalfne effect of the aminoethylphenylethers [7], "as well known" has 
been earlier examined. The aim of our earlier examinations was to see', the effect 
of the exchange in the ether oxygen to sulphur causes [5]. It was noted that the tertian' 
amino-ethyl-aryl-thioethers become adrenaline mobilisers and ganglion excitators. 
So this isoster exchange proves a significant change of pharmacological properties. 
The first effective and in the medical practice still used aminoether derivatives was 
produced by F O U R N E A U [ 7 ] . Later investigating systematically this group numerous 
compounds were demonstrated possessing antihistamine and nicotine-like effect. 
[7, 8] Efforts were made to contribute to some new details to the problem. 
The general formulae of the compounds synthetized: 
X A r - 0 ( C H 2 ) 2 - N - R r R 2 
The synthesis of this group could be realized merely in several steps. The synthesis 
of halogen ethylaryl-ethers started from phenols was determined by W O H L and 
B E R T H O L D [ 9 ] with dihalogenethane and the halogen-ethylarylether obtained could 
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be connected with various secondary basis and so the above mentioned group can 
be reached. 
ArOH -f-X .(CH2)2 .X -^itL» Ar.O.(CH 2 ) 2 .X 
X = halogen atom 
The disadvantage of this synthesis is that it may easily result diarylethylether. 
However with P E R K I N ' S [ 1 0 ] method the chlorethyl-group yields better results 
with alcohols and phenols. In this method /?-chlorethyl-p-toluene-sulfonic acidesters 
are employed for the intake of the chlorethyl-group: 
Ar.OH + H" 3 C.C 6 H 4 .S0 2 .CH 2 .CH 2 .C1 
. NaOH 
Ar. O. CH 2 . CH 2 . CI + H3C. C 6 H 4 . S0 2 .OH 
The method is mainly used to prepare naphthoyl ethers. 
K I R N E R [ 1 1 ] synthetized the ^-chlorethyl-phenolethers in two steps. The phenyl-
ethanol-ether is formed first at the reaction taking place' between the phenol and 
ethylenechlorhydrine in alkalic solution: 
ArOH + CI. CH 2 . CH 2 . OH 
NaOH 
A r . O . C H 2 . C H 2 O H + HCl 
which can be transformed into /i-chlorethylphenyl-ethcr with thionyl-chloride: 
Ar. O. CH 2 . CH 2 . OH 
SOCl2 
A r . O . C H 2 . C H 2 . C l 
Aryl-thioether may be also obtained with this method [12]. 
The halogenethylphenyl-ether was reacted, with the excess of secondary amines 
(piperidine, pyrrolidine, morpholine, ethylamine) in dry pyridine. • 
A r . O . C H 2 . C H 2 . C l + 2 H N . R 1 . R 2 
i 
Ar.O.CH 2 .CH 2 .N.R. ' , ,R 2 +HC1.HN.R-! .R2 
After having the hydrochlorides of the above mentioned substances reacted with 
calculated amount of alcoholic hydrochloric aeid and the methoiodides with methyl-
iodide in ethanol. 
A r . O . C H 2 . C H 2 . N . R 1 . R 2 . H C l 
A r . O . C H 2 . C H 2 . N . R 1 . R 2 ^ r < ; 
A r . O . C H 2 . . C H 2 . N . R 1 . R 2 ] J ( _ l 
C H , 
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Experimental 
/1-hydroxyethy/phenyl-ether (11) 
17 gr of NaOH is solved in 20 ml of water and added to 30grof phenol. Jt is heated 
in water-bath and 24,4 gr ethylenechlorohydrine is added slowly stirring and constantly 
heating it for 10 minutes, than cool it. It results two phases, the water phase is sepa-
ratedfrom the oil and extracted with ether. Combine the upper phase and the ether 
extracts, washed 3—4 times with 20 ml of water and the etheric solution is dried 
(Na 2S0 4) . After a while the solvent is distilled, the residue is fractionated. 
Bp.: 128-130 °C/20 mm. 
Yield: 84%. . ~ 
[i-ch/oroethyl-phenylether ( I I ) 
30 gr of pyridine is added to 35 gr of /J-hydroxyethyl-phenylether and slowly 
dropwise 30 ml of fresh distilled thionylchloride added (in the caseof rapid reaction 
is cooled in ice), heat it in water bath for a short while thereafter cool it then pour 
it into ice cold water whereupon the product is crystallized. After filtering it is 
washed with water, diluted N a H C 0 3 solution and is solved in ether. The ether is 
dried (Na2S04), filtered and finally distilled. The oil-like residue is fractionated. 
Bp.: 217-220 °C. 
Bp.: 122-123 °C/26 mm. 
Mp.: 2 7 - 2 8 °C. 
Yield: 88%. 
(j-bromoethylpheny/-ether (9) 
14 gr of phenol is mixed with 15 ml of dibromoethane and 50 ml of water is 
added to it. Refluxed for a time in oil-bath at 100—105 °C constantly stirring it. 
4 ml (4 N) of NaOH solution is slowly dropped into it. Filtering it in hot condition 
and let it cool. Two layers are formed following the cooling. The oil-layer is 
separeted and the aqueous part is repeatedly extracted with ether. The oil-phase and 
the ether extract are combined washed with diluted NaOH. Drying (Na 2S0 4) , the 
filtrate distilled and the residue is fractionated. 
Bp.: 114-117 C/lOmm. 
Yield: 59%. 
P-ch/oroethylpheny¡ether (10) 
38 gr of phenol, 17 gr of NaOH solved in 30 ml of water adding to this 94 gr of 
/J-chloroethyl-p-toluenesulfuric acidester is heated in water bath for 2—3 hours 
constantly stirring. Turning it into basic with potash following steam distillation 
it an agreeable smelling distillate is obtained. (During the steam-distillation 1—2 gr 
of diphenylethylen ether is formed in the cooler.) The oil has been separated, 
dried (Na 2S0 4) and fractionated. ~ 
Bp.: 217-220 °C. 
Yield: 90%. 
P-bromoethyl-naphthoylether (9) 
4 gr of NaOH solved in 50 ml of water is added to 21,6 gr of /?-naphthol 
and 28,2 gr of dibromethane. Stirring it for 24 hours and keeping it refluxed in 
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oil-bath at 100—110 °C. After cooling two layers are separated. The water phase 
is extracted as above. The oil phase and the ether extract are combined, dried 
(Na 2S0 4 ) and the ether evaporates, the residue is recrystallized from alcohol. 
Mp.: 96 °C. 
Yield: 40%. 
N-piperidino-ethylpheny ¡-ether 
17,03 gr (0,2 M) of piperidine is added to 15,66 gr (0,1 M) of /?-chloroethyl-
phenylether and reflux it in oil-bath at 150 °C for 30 minutes. Piperidine—HC1 is 
precipitated then filter it, wash with dry benzene. The benzene as well as the un-
reacted piperidine are distilled and the residue is fractionated in vacuum. (Tabl. II 
and III show the bp., physical constants and analysis of compounds). 
N-pirro!idino-ethylpeny ¡ether 
14,22 gr (0,2 M) of pirrolidine was added to 15,66 gr (0,1 M) of /?-chloroethyl-
phenyl-ether. It was refluxed in oil bath at 140 °C for 1 hour. It results a jelly-like 
precipitate of pirrolidine-HCI. The pirrolidine-HCl and the unreacted pirrolidine 
is washed with water as well as diluted potash. The fluid is three times extracted 
with ether, dried (Na2S04), then the solvent is evaporated. The residue is fractionated. 
(Tabl. II and III). 
N-morpholinoethylphenyl-ether 
17,43 gr (0,2 M) of morpholine is added to. 15,66 gr (0,1-M) of /?-chloroethyl-
phenyl ether. Keeping refluxed in oil-bath at 170—175 °C for 1 hour. After cooling 
morpholine-HCl crystals are precipitated filter it and washed with dry benzene. The 
residue after evaporation is fractionated. (Tabl. II and III). 
N-diethylaminoethyl-phenylether 
21,74 gr (0,3 M) of diethylamine is added to 15,66 gr (0,1 M) of /J-chloroethyl-
phenylether. It is refluxed in oil-bath at 150 °C for 3—4 hours. The rest of the pro-
cedure is followed as above (Tabl. II and III). 
2,4-dichlorophenyl-[3-hydroxy-ethylether 
82 gr of 2,4-:dichlorophenol is solved in 200 gr 10% of NaOH and add 47 gr 
of ethylenechlorohydrine refluxed it for 12 hours. After cooling it is extracted with 
ether and the extract is washed with 5% NaOH solution. The ether is evaporated 
and the oil like residue is fractionated. 
Bp.: 158-160 °C/11 mm. 
Mp.: 5 7 - 5 8 °C. 
Yield: 42,8%. 
2,4-dichlorophenyI-P-chloroethyIether 
46 gr of PC15 is added, to 44,5 gr of 2,4-dichlorophenyl-j8-hydroxyphenyl-
ether and heated over asbestos. The reaction rapidly occurs. The by-product is dis-
tilled and oil-like residue is fractionated. 
Bp.: 126—127-°C/8 mm. 
Yield: 63,58%. 
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2,4-dichlorophenyl-fi-bromo-ethylether. (13) 
326 gr (2 M) of 2,4-dichlorophenoJ, 470 gr of dibromoethane and 1 1 of dis-
tilled water are put in a 3-necked flask of 3 1 contant. It is refluxed with constant 
stirring while 8 gr (2,1 M) of NaOH solution is beeing added for 1 hour. After 
cooling the two phases are separated and the upper one is washed, dried (Na 2S0 4 ) , 
filtered and fractionated. 
Bp.: 157-159 °C/1 Omm. 
Yield: 69%. 
N-piperidino-ethyl-2,4-dichlorophenylether 
10 gr of /?-bromoethyl-2,4-dichlorophenylether is added to 6,7 gr of piperidine 
solved in 20 ml of dry benzene and refluxed 50 minutes. After cooling is filtered 
and washed with benzene. The solvent is distilled and the oily residue is fractionated. 
(Tabl. II and III). 
N-diethylaminoethyl-2,4-dichlorophenylether 
9,5 gr of diethylamine is added to 15 gr of /?-bromoethyi-2,4-dichlorophenyI-
ether and refluxed at 150 °C for 3 hours. After cooling it is filtered, the precipitate 
is washed with benzene. The solvent is distilled and from the residue results in 
hydrochloride with alcoholic HC1. 
p-toluene sulfonic acid chloride is prepared with the method described by V O G E L . 
[14]. 
ji-chloroethyl-p-toluene sulfonic acidester (10) 
95 gr of p-toluenesulfonic acidchloride with 100 gr of ethylenechlorohydrine is 
refluxed 155—160 °C (HC1 gas is formed) for about 2—3 hours. The excess of 
ethylenechlorohydrine is distilled (over 60 gr) in vacuum. The residue is alkalized 
with diluted excess of NaOH and extracted with benzene. The combined extract is 
dried (K2C03) , filtered and distilled. The residue is fractionated. 
Bp.: 210 °C/21 mm. 
Bp.: 155-157 °C/3 mm. 
Yield: 87%. 
fl-chloroethy I-(i-naphthy tether (10) 
8 gr of NaOH and 47 gr of /?-chloroethyl p-toluene sulfonic acid ester sold in 
14 ml of water are added to 30 gr of /3-naphthol. It is stirred and heated in steam-bath 
for 1 hour. The product is solidified while cooled, then ground and dried in an 
exsiccator over potash. The by- product /?-naphthylether can be spearated by petro-
leum ether extraction. Having concentrated the petroleum ether extract the expected 
material is crystallized in plate forms. 
Mp.: 83 °C. 
Yield: 75%. 
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¡3-chloroethyl ot-naphthyl-ether. (10) 
It is produced like the /?-chloroethyl-/?-naphthylether. 
Mp.: 28 °C. 
Bp. : 202 °C/16 mm. 
Bp.: 172-175 °C/3 mm. 
Yield: 51%. 
11-piperidinoethyl-x-naphthylether 
17,03 gr (0,2 M) of piperidine is added to 20,67 gr (0,1 M) of jS-chloroethyl-
«-naphthylether. It is kept at 150—160 °C for 1 hour. The precipitate is filtered, 
washed with benzene and dried (Na2S04) . The solvent is distilled and the residue 
is fractioneted. 
(Tabl. II; and III). 
P-pirrolidinoethyl-a-naphthylether 
14,22 gr (0,2 M) of pirrolidine is added to 20,67 gr (0,1 M) of ^-chloroethyl-a 
naphthylether. Refluxed at 140 °C for 2 hours. After cooling the precipitate is fil-
tered, washed with benzene and the solvent evaporated and the residue is fractionated 
(Tabl. II and III). 
ft-piperidinoethyl-fl-naphthylet/ier 
20,67 gr (0,1 M) of /?-chloroethyl-/J-naphthylether is solved in 17,03 gr (0,2 M) 
of piperidine. The solution is kept in oil bath at 150 °C for 0,5 hour. After cooling 
a piaecipitate is obtanied, it is filtered and washed with benzene. The solvent is 
distilled and the residue is fractioned. (Tabl. II and III). 
fi-pirrolidino-ethyl-fl-naphthy/ether 
It was produced similarly to the afore said method. 
Preparation of hydrochlorides 
The basis is solved in absolute ethanol or ether and reacted with calculated 
amount of ethanolic and etheric hydrochloric acid. 
Preparation of methoiodides 
The basis is solved in abs. ethanol and reacted with the calculated amount 
of methyliodide. 
Keeping it for a couple of days at room temperature the quaterner compounds 
are precipitated. Filtered it and recrystallized from dry ethanol. 
They are light sensitive. 
* * * 
The authors wish to express their thanks to J . FÜLÖP , technician, for the analyses 
carried out in the Analytical Section of our Institute as well as to Gedeon Richter 
Pharmaceutical Works, Budapest for their kind support. 
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Table I (Pharmacological effect) 
Basis Te r t i a ry (HCI ) Q u a t e r n a r y m e t h o i o d i d e 
C 6 H 5 O ( C H 2 ) 2 N C J H , 0 antiadrenalinic effect (100) slight ganglion excitator 
C 6 H 5 0 ( C H 2 ) 2 N - C 4 H S antiadrenalinic effect (50) -
C 6 H 5 0 ( C H 2 ) 2 - N - C 4 H 8 0 antiadrenalinic effect (10) somewhat nicotine-like 
effect 
C 6 H 3 C I 2 - O - ( C H 2 ) 2 - N C 5 H 1 0 antiadrenalinic effect (20) slight ganglioplegic 
C 6 H 3 - C l 2 - O - ( C H 2 ) 2 - N - C 4 H 1 0 antiadrenalinic effect (30) -
C 6 H 5 O - ( C H 2 ) 2 - N - C 4 H L 0 antiadrenalinic effect (100) -
a - C . o H j - O - i C H i i r N - C s H . o slight antiadrenalinic effect slight ganglioplegic 
a - C i o H 7 0 - ( C H 2 ) 2 - N - C 4 H 8 adrenaline mobilizer slight ganglioplegic 
J 8 - C I O H 7 - 0 ( C H 2 ) 2 - N - C 5 H , O no effect on adrenaline strong ganglioplegic 
(3 X TEA) 
J f f -C l o H 7 -0 (CH2)2-N-C4H 8 no effect on adrenaline ganglioplegic ( 1 X T E A ) 
( + ) ( " ) 
€ 6 H 5 - 0 - ( C H ! ) 2 - N ' C i H , O - J 
CH:CsH5 
- strong ganglioplegic 
( 3 X T E A ) 
Table III 
Ter t i a ry h y d r o c h l o r i d e 
N u m b e r 
M p . 
Ca lcu la ted % F o u n d Y0 
°C c H N C K - > c H N ci<-> 
1 175 64,67 8,38 5,79 14,67 64,75 8,32 5,67 14,49 
2 154 50,27 7,97 6,15 15,57 50,13 7,88 . 5,94 15,39 
3 189 59,13 7,03 5,75 14,55 59,27 7,20 5,62 14,47 
4 145 62,72 8,82 6,10 15,43 62,50 8,77 6,05 15,30 
5 172 50,04 5,85 4,51 11,32 50,25 5,93 4,70 11,20 
6 134 48,40 6,07 4,96 12,00 48,72 6,21 4,79 12,31 
7 175 61,60 7,62 4,79 12,12 61,45 7,63 4,77 12,10 
8 152 69,17 7,26 5,04 12,76 69,38 7,20 5.03 12,65 
9 209 61,60 7,62 4,79 12,12 61,62 7,55 4,81 12,02 
10 208 69,17 7,26 5,04 12,76 69,40 7,15 5,00 12,70 
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Basis S u m m a r y f o r m M o l . wt . 
Bp . 




1 . C S H S - C M C H ^ - N - C S H . O C I 3 H 1 9 O N 2 0 5 , 2 9 1 3 1 / 1 1 , 5 2 8 0 2 5 7 5 
2 . C 6 H 5 - 0 - ( C H 2 ) 2 - N - C 4 H 8 C , 2 H 1 7 O N 1 9 1 , 2 7 1 1 4 / 1 1 , 5 2 7 0 " 6 8 
3 . C 6 H 5 - 0 - ( C H 2 ) 2 - N C 4 H 8 0 C , 2 H , 7 0 2 N 2 0 7 , 2 6 1 4 6 / 4 1 , 5 3 2 0 2 5 7 3 
4 . C 6 H 5 - O - ( C H 2 ) 2 - N - C 4 H l 0 C 1 2 H 1 9 O N 1 9 3 , 2 9 1 3 1 / 5 - 3 2 
5 . C 6 H 3 - C l 2 - O - ( C H 2 ) 2 - N - C 5 H , 0 C i 3 H l 7 O N C l 2 2 7 4 , 1 4 1 4 6 / 2 , 5 - 6 2 
6 . C E H J - C h - C K C H I ^ - N ^ H . o C , 2 H 1 7 O N C l 2 2 6 2 , 1 9 - - -
7 . a - C i o H 7 - O - ( C H 2 ) 2 - N - C 5 H 1 0 C 1 7 H 2 1 O N 2 5 5 , 3 5 1 2 0 / 2 - 3 - 5 2 
8 . A - C 1 0 H 7 - O - ( C H 2 ) 2 - N - C 4 H s C , 6 H 1 9 O N 2 4 1 , 3 2 1 1 6 / 3 - 4 8 
9 . / ? - C I O H 7 - 0 - ( C H 2 ) 2 - N - C 5 H I O C 1 7 H 2 1 O N 2 5 5 , 3 5 1 5 0 - 1 6 0 / 3 - 4 - 5 1 
10. y ¥ - C I O H 7 - 0 ' ( C H 2 ) 2 ' N - C 4 H I O C I 6 H 1 9 O N 2 4 1 , 3 2 1 4 0 - 1 4 5 / 3 - 5 1 
( c o n t i n u e d ) 
N u m b e r 
Q u a t e r n a r y m e t h o i o d i d e 
M p . 
° C 
Ca lcu la ted °/a F o u n d °/o 
C H N j ( - ) c H N j ( - > 
1 1 3 0 4 8 , 4 5 6 , 3 9 4 , 0 3 3 6 , 5 4 4 8 , 7 2 6 , 2 5 4 , 0 2 3 6 , 1 7 
'3 1 0 5 4 4 , 7 0 5 , 8 0 4 , 0 1 3 6 , 3 3 4 4 , 8 7 5 , 8 5 4 , 2 2 3 6 , 0 1 
5 1 6 5 - - - 3 1 , 9 2 - - - 3 1 , 4 0 
7 1 3 2 5 4 , 4 2 6 , 0 9 3 , 5 3 3 1 , 9 5 5 4 , 7 0 6 , 0 0 3 , 3 9 3 1 , 6 2 
8 1 2 5 5 3 , 2 7 5 , 7 9 3 , 6 6 3 3 , 1 1 5 3 , 2 2 5 , 7 7 3 , 5 8 3 2 , 8 9 
9 1 5 2 5 4 , 4 2 6 , 0 9 3 , 5 S 3 1 , 9 5 5 4 , 6 7 6 , 2 3 3 , 4 7 3 1 , 5 5 
1 0 1 2 4 5 3 , 2 7 5 , 7 9 3 , 6 6 3 3 , 1 1 5 3 , 2 2 ' 5 , 6 6 3 , 6 2 3 2 , 9 7 
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И З У Ч Е Н И Е ДЕЙСТВИЯ М Е Ж Д У ФИЗИОЛОГИЧЕСКИМИ И ХИМИЧЕСКИМИ 
СТРОЕНИЯМИ ВЕЩЕСТВ, ДЕЙСТВУЮЩИХ НА Ц Е Н Т Р А Л Ь Н Ы Й 
НЕРВНЫЙ МОЗГ. IV 
Синтез терциераминовых ациламидов 
III. Фельдеак, Й. Цомдош, Б. Маткович и Й. Порсас 
У ж е известными способами была изготовлена несколько Р• О• (СН2)2 , И Р , Р 2 , 
производных типа аминовалкил — этилового эфира, где радикал Р являлся замещ-
ённым фениловым нафтиловым радикалом. ИР. Р 2 =. Диетиламино- гтиперидино-, пи-
пеолидино-, или морфолиновым основаниям. 
Из этих соединений было изготовлено несколько квагернерных производных. 
Рассматривая их фармаколог ическую активность, установилось, что терциерные 
соединения обладали активностью антиадреналина. Между кватерническими производ-
ными ж е встречались очень активные блокирующие ганглиона. 
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